Latest stories on CELC
Celcuity Inc. (CELC) Discusses VIKTORIA-1 Trial Results for PIK3CA Mutant Advanced Breast Cancer and Gedatolisib Efficacy - Slideshow
Seeking Alpha58 · neutralproduct/pr
Celcuity raises $500M in upsized 0.25% convertible notes sale
Seeking Alpha58 · neutralproduct/pr
Celcuity: Selloff On Yesterday's Data Unwarranted; Buy Rating Upheld
Seeking Alpha61 · neutralanalyst
Celcuity announces $400M convertible notes offering
Seeking Alpha53 · neutralgeneral
Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032 | CELC Stock News
StockTitan58 · neutralgeneral
Celcuity Inc. (CELC) Discusses VIKTORIA-1 Trial Results for PIK3CA Mutant Advanced Breast Cancer and Gedatolisib Efficacy Transcript
Seeking Alpha58 · neutralproduct/pr
Celcuity falls after detailed late-stage trial data for breast cancer drug
Seeking Alpha33 · bearishearnings
Celcuity highlights positive Phase 3 gedatolisib breast cancer data
TipRanks77 · bullishproduct/pr
Celcuity To Participate in Upcoming Investor Conferences | CELC Stock News
StockTitan53 · neutralproduct/pr
CELC: [Form 4] Celcuity Inc. Insider Trading Activity
StockTitan SEC50 · neutralgeneral
Celcuity’s Gedatolisib Shines Amid Mounting Cash Burn
TipRanks58 · neutralearnings